This Insider Sold 1,000 Shares: Signals and Implications
Insider trading activity can reveal how executives view their company’s future. This article digs into a real-world c...
Articles — Page 1289
How Much Should Have Saved by 60? A Retirement Guide
Hitting 60 is a pivotal moment. This guide explains how much you should have saved by 60, what to aim for in your 401...
Stocks March: Two Compelling Buys for March Investing
As March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...
Tech Invest $1,000 Right: Choose This Best ETF Today
Want to put $1,000 into tech without picking individual stocks? This guide recommends a single, low-cost tech ETF, ex...
Greg Abel Just Took a Page From Buffett's Playbook
When leadership shifts at Berkshire Hathaway, the market takes notice. This piece explains how greg abel just took cu...
Magnificent Dividend Stock Down 36%: Buy and Hold Forever
A down-market pullback can create a rare buying opportunity. This article explains how to spot a magnificent dividend...
Evernorth XRP Treasury Firm Eyes Nasdaq SPAC Listing
Evernorth moves to go public through a SPAC merger, aiming to convert XRP exposure into a participatory, yield-genera...
Nigel Farage Cameo Videos Fueled Crypto Pump Schemes
Fraudsters used Nigel Farage cameo videos to push unregulated crypto tokens, sparking rapid price spikes and steep de...
Animoca Brands Invests AVAX to Expand Avalanche in Asia
Animoca Brands announces a strategic investment in the AVAX token and a partnership with Ava Labs to accelerate Avala...
This Crypto Firm Cuts Jobs to Speed AI Integration Push
NovaBridge Crypto cuts 12% of its workforce to accelerate its AI strategy, signaling a wider shift toward AI-driven e...
Over $2B Lost Bitcoin Markets Set to Hit This Month
A wave of previously inaccessible BTC could re-enter markets in March, testing a fragile price zone and highlighting ...
The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...